|
|
Autism Research Institute
Autism Research Review International
1987 to 2004, Volumes 1 to 18
I
IARET. See International Assocation for the Right to Effective Treatment (IARET)
IBM SpeechViewer, 1999, Vol. 13(3) pp. 6
ICBR. See Institute for Child Behavior Research
IDEA. See Individuals with Disabilities Education Act
IDRP (Intellectual Disability Review Panel of Victoria), 1991, Vol. 05(1) pp. 1; 1991, Vol. 05(2) pp. 6.
IgE (immunoglobulin E), 2002, Vol. 16(4) pp. 5; 2003, Vol. 17(2) pp. 5.
IGF-1. See insulin-like growth factor-1
IgG antibodies, 1999, Vol. 13(2) pp. 4; 2002, Vol. 16(4) pp. 4.
IgM antibodies, 1999, Vol. 13(2) pp. 4
ileal lymphoid nodular hyperplasia (LNH), 2004, Vol. 18(2) pp. 1; 2004, Vol. 18(3) pp. 7.
ileitis, 2000, Vol. 14(4) pp. 1
ileocolitis, 2002, Vol. 16(2) pp. 1
ileocolonic lymphoid nodular hyperplasia (LNH), 2000, Vol. 14(4) pp. 2
Illinois, 2004, Vol. 18(4) pp. 3
IMA (International Mobilization against Autism), 1996, Vol. 10(4) pp. 6
imagery, 1988, Vol. 02(4) pp. 5; 1989, Vol. 03(1) pp. 2.
IMGSAC genetic study, 2000, Vol. 14(1) pp. 2
imipramine, 1987, Vol. 01(1) pp. 4; 1991, Vol. 05(1) pp. 3; 1991, Vol. 05(2) pp. 4.
imitation skills, 2001, Vol. 15(3) pp. 4; 2002, Vol. 16(4) pp. 2.
immersion virtual reality, 1997, Vol. 11(1) pp. 5
immobilization time-outs, 1989, Vol. 03(1) pp. 5
immune dysfunction
a-MSH (a-melanocyte stimulating hormone) for, 2003, Vol. 17(1) pp. 7
and albumin concentrations, 2002, Vol. 16(4) pp. 4
and antibiotics, 2004, Vol. 18(2) pp. 7
biopterin levels in autistics, 1999, Vol. 13(1) pp. 4
and brain abnormalities, 1987, Vol. 01(2) pp. 2
brain autoantibodies (See autoantibodies, brain)
brainstem myelination defect, 1993, Vol. 07(1) pp. 5
celiac disease, 1993, Vol. 07(1) pp. 4
in chemokines, 2004, Vol. 18(4) pp. 1
in cytokines, 2004, Vol. 18(4) pp. 1
dialyzable leukocyte extract for, 1989, Vol. 03(4) pp. 1
dialyzable lymphocyte extract for, 1997, Vol. 11(2) pp. 1
"dose effect" in autistics' families, 1997, Vol. 11(4) pp. 5
DPP IV protein for, 2002, Vol. 16(2) pp. 4
and ear infections, 1994, Vol. 08(4) pp. 1
and glutathione deficiency, 2004, Vol. 18(4) pp. 1
helper T cells, 1987, Vol. 01(2) pp. 2
HLA and fetal damage, 1987, Vol. 01(2) pp. 2
and HUFA (highly unsaturated fatty acid) deficiency, 2000, Vol. 14(4) pp. 6
IgG concentrations and chronic viral infections, 2002, Vol. 16(4) pp. 4
inflammatory bowel disease autistic variant, 2002, Vol. 16(2) pp. 1
intravenous gammaglobulin (IVIG) therapy for, 1995, Vol. 09(2) pp. 7; 1996, Vol. 10(3) pp. 1; 1997, Vol. 11(1) pp. 1.
Lactobacillus GGq, 2001, Vol. 15(3) pp. 4
Landau-Kleffner syndrome as, 1997, Vol. 11(1) pp. 1; 1999, Vol. 13(2) pp. 4.
and liver detoxification defects, 1998, Vol. 12(3) pp. 2
lymphocytes, 1987, Vol. 01(2) pp. 2; 1993, Vol. 07(4) pp. 1; 1994, Vol. 08(2) pp. 4; 2003, Vol. 17(4) pp. 1.
major histocompatibility complex (MHC), 1996, Vol. 10(4) pp. 2
maternal antibodies and autism, 2003, Vol. 17(1) pp. 6
measles, 2001, Vol. 15(4) pp. 7; 2003, Vol. 17(2) pp. 6.
mercury poisoning and autistic symptoms compared, 2000, Vol. 14(2) pp. 7
from metal toxicity, 2002, Vol. 16(3) pp. 2
natural killer cells, 1987, Vol. 01(2) pp. 2
neopterin levels in autistics, 1999, Vol. 13(1) pp. 4
PANDAS (pediatric autoimmune neuropsychiatric disorders), 1998, Vol. 12(2) pp. 2
from peptides, 2002, Vol. 16(1) pp. 7
probiotics for, 2001, Vol. 15(3) pp. 4
screening for prior to vaccination, 2003, Vol. 17(2) pp. 5
and sensory issues, 1996, Vol. 10(4) pp. 3
serotonin and, 1987, Vol. 01(2) pp. 2; 1996, Vol. 10(4) pp. 2.
strep, 1998, Vol. 12(2) pp. 2
supplements for, 1993, Vol. 07(4) pp. 1; 2000, Vol. 14(1) pp. 6.
and toxics, 1998, Vol. 12(3) pp. 2
and tryptophan depletion in autistics, 1999, Vol. 13(4) pp. 4
TSP (total serum protein) and social deficits, 2002, Vol. 16(4) pp. 4
tumor necrosis factor-alpha and autism, 1997, Vol. 11(1) pp. 2
from vaccines, 1996, Vol. 10(1) pp. 3; 1999, Vol. 13(3) pp. 6; 2001, Vol. 15(1) pp. 2; 2001, Vol. 15(2) pp. 3; 2002, Vol. 16(3) pp. 1.
zonulin's role in, 2000, Vol. 14(2) pp. 2
immune gammaglobulin (IgG), 2002, Vol. 16(4) pp. 4
immunization. See also vaccines
Immunization, Theory vs. Reality (Miller), 1998, Vol. 12(1) pp. 3
immunoglobulin E (immunoglobulin E), 2002, Vol. 16(4) pp. 5; 2003, Vol. 17(2) pp. 5.
immunotherapy. See also Biological Treatments
impotence, 2001, Vol. 15(2) pp. 4; 2001, Vol. 00(2) pp. 4.
imprinting
impulsivity
clomipramine for, 1992, Vol. 06(4) pp. 5
clonidine for, 1992, Vol. 06(3) pp. 2
divalproex sodium (Depakote) for, 2001, Vol. 15(3) pp. 5
from Epstein-Barr infection, 2001, Vol. 15(1) pp. 4
gluten and, 1999, Vol. 13(2) pp. 6
from PANDAS (pediatric autoimmune neuropsychiatric disorders), 1998, Vol. 12(2) pp. 2
supplements and Ritalin compared for, 2003, Vol. 17(4) pp. 7
from withdrawal from SRIs and SSRIs, 1998, Vol. 12(2) pp. 6
incidental language teaching, 1987, Vol. 01(4) pp. 5
inclusion. See also mainstreaming
for autistic adults in the community, 1993, Vol. 07(4) pp. 3; 1994, Vol. 08(1) pp. 6.
educational benefits, 1993, Vol. 07(3) pp. 6; 1998, Vol. 12(1) pp. 5.
educational problems, 1992, Vol. 06(4) pp. 1; 1993, Vol. 07(1) pp. 3; 1993, Vol. 07(2) pp. 6; 1993, Vol. 07(4) pp. 2; 1994, Vol. 08(1) pp. 6; 1994, Vol. 08(4) pp. 1; 1995, Vol. 09(4) pp. 1; 1998, Vol. 12(1) pp. 5.
peer friends, 1998, Vol. 12(1) pp. 5
increasing prompt hierarchy, 1988, Vol. 02(2) pp. 6
independent living. See also life skills
bill paying, 1994, Vol. 08(4) pp. 5
choices, 1991, Vol. 05(2) pp. 5
color coding, 1990, Vol. 04(2) pp. 5
crime, 2000, Vol. 14(2) pp. 7
and inclusion, 1992, Vol. 06(4) pp. 1
sensory integration therapy in, 1991, Vol. 05(2) pp. 6
Individual Education Plans (IEPs), 1993, Vol. 07(2) pp. 2
Individual Family Service Plans (ISPs), 1993, Vol. 07(2) pp. 2
Individual Habilitation Plans (IHPs), 1993, Vol. 07(2) pp. 2
individuality, 2001, Vol. 15(1) pp. 3
Individuals with Disabilities Education Act (IDEA)
Infantile Autism (Rimland), 1989, Vol. 03(1) pp. 3; 1989, Vol. 03(3) pp. 3; 1993, Vol. 07(1) pp. 5; 1993, Vol. 07(2) pp. 3; 1994, Vol. 08(1) pp. 3; 1996, Vol. 10(1) pp. 1; 1997, Vol. 11(2) pp. 3; 1998, Vol. 12(2) pp. 3; 2001, Vol. 15(3) pp. 3; 2003, Vol. 17(4) pp. 3.
infantile reflexes, 2004, Vol. 18(3) pp. 5
infantile spasms, 1994, Vol. 08(1) pp. 1; 1994, Vol. 08(3) pp. 1.
infants, 1999, Vol. 13(1) pp. 1; 2004, Vol. 18(3) pp. 5.
infections
anthrax, 2002, Vol. 16(4) pp. 3
and autism, 1999, Vol. 13(1) pp. 4
and auto-immune disorders, 1993, Vol. 07(1) pp. 5
and blood-brain barrier, 1993, Vol. 07(1) pp. 4
Borna virus and mental illness, 1996, Vol. 10(3) pp. 5
cytomegalovirus (CMV), 1990, Vol. 04(4) pp. 4
Dialyzable Leukocyte Extract for, 1989, Vol. 03(4) pp. 1
dialyzable lymphocyte extract for, 1989, Vol. 03(4) pp. 1
Epstein-Barr, 2001, Vol. 15(1) pp. 4
herpes simplex, 1997, Vol. 11(2) pp. 2
and inflammatory bowel disease in autistic children, 2003, Vol. 17(4) pp. 1
Landau-Kleffner and, 1991, Vol. 05(1) pp. 2
maternal influenza, 2003, Vol. 17(2) pp. 2
measles (see measles)
neurological problems and, 1987, Vol. 01(1) pp. 4; 1987, Vol. 01(2) pp. 2; 1988, Vol. 02(3) pp. 4; 1991, Vol. 05(1) pp. 5; 1993, Vol. 07(1) pp. 4.
probiotics for, 2001, Vol. 15(3) pp. 4
and reelin in autism, 2001, Vol. 15(2) pp. 1
slow viruses, 1989, Vol. 03(4) pp. 1; 1991, Vol. 05(1) pp. 2.
and Tourette's, 1996, Vol. 10(3) pp. 1; 1997, Vol. 11(2) pp. 2; 1998, Vol. 12(2) pp. 2; 1999, Vol. 13(1) pp. 5; 2000, Vol. 14(2) pp. 4; 2002, Vol. 16(1) pp. 4.
inflammatory bowel disease
Crohn's disease, 1996, Vol. 10(4) pp. 1; 1998, Vol. 12(1) pp. 6; 2000, Vol. 14(2) pp. 7.
and HUFA (highly unsaturated fatty acid) deficiency, 2000, Vol. 14(4) pp. 6; 2002, Vol. 16(2) pp. 4.
ileitis, 2000, Vol. 14(4) pp. 1
ileocolitis, 2002, Vol. 16(2) pp. 1
and measles virus, 2000, Vol. 14(2) pp. 7; 2000, Vol. 14(4) pp. 1; 2001, Vol. 15(4) pp. 2; 2002, Vol. 16(1) pp. 1; 2002, Vol. 16(2) pp. 1.
ulcerative colitis, 2000, Vol. 14(2) pp. 7; 2000, Vol. 14(4) pp. 2.
variants in autistics, 2000, Vol. 14(4) pp. 2; 2004, Vol. 18(2) pp. 3.
influenza, 2003, Vol. 17(2) pp. 2
informed consent for vaccines, 1999, Vol. 13(3) pp. 7
Ingram, J. L., 2000, Vol. 14(3) pp. 5
inositol, 1997, Vol. 11(2) pp. 1–2
Insel, Thomas, 1992, Vol. 06(3) pp. 4; 1996, Vol. 10(3) pp. 2.
insomnia. See also sleep problems
and behavior problems, 1993, Vol. 07(3) pp. 5
diet for, 1989, Vol. 03(3) pp. 4
drugs for, 1989, Vol. 03(3) pp. 4; 1992, Vol. 06(3) pp. 4.
substitute moms for, 1993, Vol. 07(4) pp. 5
supplements (DMG) for, 1994, Vol. 08(3) pp. 2
supplements (magnesium) for, 1992, Vol. 06(1) pp. 7; 1994, Vol. 08(2) pp. 6; 1994, Vol. 08(3) pp. 6.
supplements (melatonin) and, 1993, Vol. 07(3) pp. 4; 1994, Vol. 08(3) pp. 6.
supplements (vitamin B6) for, 1992, Vol. 06(1) pp. 7; 1994, Vol. 08(2) pp. 6; 1994, Vol. 08(3) pp. 1.
Institute for Child Behavior Research (ICBR)
candida link, 1988, Vol. 02(1) pp. 7
Diagnostic Checklist, 1988, Vol. 02(3) pp. 1
lithium study, 1988, Vol. 02(1) pp. 7
R-THBP clinical trials, 1990, Vol. 04(4) pp. 1
sound sensitivity study, 1990, Vol. 04(4) pp. 6
treatment comparison study, 1988, Vol. 02(2) pp. 2
Institute for Disabilities at the University of New Hampshire, 1993, Vol. 07(2) pp. 1
Institute for Safe Medical Practices, 1996, Vol. 10(3) pp. 4
Institute of Medicine (IOM), 2001, Vol. 15(2) pp. 3; 2001, Vol. 15(3) pp. 1; 2004, Vol. 18(2) pp. 3.
institutions
and community residential care compared, 1991, Vol. 05(3) pp. 3; 1993, Vol. 07(2) pp. 2; 1993, Vol. 07(4) pp. 3; 1995, Vol. 09(3) pp. 1; 1995, Vol. 09(4) pp. 6; 1996, Vol. 10(4) pp. 1; 1997, Vol. 11(1) pp. 3; 1997, Vol. 11(2) pp. 6; 1999, Vol. 13(4) pp. 1.
Porterville Developmental Center, 1997, Vol. 11(1) pp. 3
violence in, 2000, Vol. 14(2) pp. 6–7
instrumental communication, 1990, Vol. 04(2) pp. 2
insulin-like growth factor-I (IGF-I), 2001, Vol. 15(4) pp. 4
integration in employment, 1990, Vol. 04(3) pp. 3
Intellectual Disability Review Panel (IDRP) of Victoria, 1991, Vol. 05(1) pp. 1; 1991, Vol. 05(2) pp. 6.
Inter-Disciplinary Party of Issues in Severe Communication Impairment, 1991, Vol. 05(1) pp. 1
interest in surroundings, 1999, Vol. 13(1) pp. 3; 1999, Vol. 13(3) pp. 2.
International Association for the Right to Effective Treatment (IARET), 1988, Vol. 02(3) pp. 6; 1989, Vol. 03(4) pp. 1; 1990, Vol. 04(3) pp. 7; 1994, Vol. 08(1) pp. 2; 1996, Vol. 10(2) pp. 3.
International Committee on Medical Journal Editors, 2004, Vol. 18(3) pp. 4
International Health Foundation, 1992, Vol. 06(3) pp. 6
International Mobilization against Autism (IMA), 1996, Vol. 10(4) pp. 6
International Rett Syndrome Association, 1999, Vol. 13(1) pp. 6
Internet discussion groups. See computer bulletin boards, websites
Internet fraud, 2002, Vol. 16(1) pp. 3
Interneuron, 1994, Vol. 08(3) pp. 2
intervention, 1995, Vol. 09(3) pp. 5. See also early intervention
intestinal enzymes, 1997, Vol. 11(3) pp. 6; 1999, Vol. 13(2) pp. 1.
intestinal permeability
and auto-immunity, 2002, Vol. 16(3) pp. 6
behavior disturbances and, 1997, Vol. 11(3) pp. 4; 2002, Vol. 16(3) pp. 2.
in gut epithelial dysfunction, 2001, Vol. 15(1) pp. 2
and peptides, 1995, Vol. 09(4) pp. 5; 1999, Vol. 13(2) pp. 1.
secretin for, 2000, Vol. 14(3) pp. 6
and tetanus, 1998, Vol. 12(4) pp. 6
intestinal symptoms. See gastrointestinal symptoms
intestinal tetanus, 1998, Vol. 12(4) pp. 1
intolerances to foods. See food intolerances
intravenous gamma globulin (IVIG) treatment, 1995, Vol. 09(2) pp. 7; 1996, Vol. 10(3) pp. 1; 1998, Vol. 12(2) pp. 1.
intussusception, 1999, Vol. 13(3) pp. 1
ionization, 1988, Vol. 02(4) pp. 4
Iowa, 2004, Vol. 18(1) pp. 9; 2004, Vol. 18(4) pp. 3.
IQ
and ABA (Applied Behavioral Analysis), 2002, Vol. 16(1) pp. 2
and academic success, 1992, Vol. 06(3) pp. 5
of autistic person and alcoholism in family, 2000, Vol. 14(1) pp. 4
bipolar brain hemisphere differences, 1999, Vol. 13(2) pp. 2
and brainstem abnormalities, 1992, Vol. 06(4) pp. 1
and cognitive improvements, 2002, Vol. 16(1) pp. 2
and conceptual problem-solving deficits, 1987, Vol. 01(4) pp. 1
and early intervention, 1991, Vol. 05(4) pp. 5; 1993, Vol. 07(1) pp. 1; 1998, Vol. 12(1) pp. 1; 2000, Vol. 14(4) pp. 2; 2003, Vol. 17(3) pp. 1.
and essential fatty acid levels in infants, 1999, Vol. 13(1) pp. 7
and extra Y chromosome, 1998, Vol. 12(4) pp. 4
and fenfluramine, 1987, Vol. 01(3) pp. 2
and Fragile X, 1988, Vol. 02(2) pp. 5; 1994, Vol. 08(1) pp. 4.
in high-functioning autistics, 1988, Vol. 02(3) pp. 4
intravenous gamma globulin therapy for, 1998, Vol. 12(2) pp. 2; 2001, Vol. 15(1) pp. 7.
and perfect pitch in autistics, 2003, Vol. 17(4) pp. 4
performance IQ in autistics' families, 1998, Vol. 12(3) pp. 2
and phenobarbital, 1990, Vol. 04(1) pp. 6
and PMA in Lovaas' statistics compared, 1987, Vol. 01(3) pp. 6
and savants' techniques, 1989, Vol. 03(1) pp. 2
secretin for, 1998, Vol. 12(3) pp. 3
seizures and, 1990, Vol. 04(1) pp. 4
in specific language impairment (SLI) and autism compared, 2000, Vol. 14(3) pp. 7
and theory of mind, 1987, Vol. 01(4) pp. 1
and Tourette's, 1987, Vol. 01(3) pp. 4
types of, 1997, Vol. 11(1) pp. 7
vitamin B6 and, 2002, Vol. 16(2) pp. 2
Irlen, Helen L., 1995, Vol. 09(2) pp. 2
Irlen Institute, 1995, Vol. 09(2) pp. 2; 1995, Vol. 09(4) pp. 6.
Irlen lenses, 1995, Vol. 09(2) pp. 2; 1995, Vol. 09(4) pp. 6; 1996, Vol. 10(4) pp. 3. See also prism lenses
iron overload, 2001, Vol. 15(3) pp. 6
irritability
from aspartame, 1992, Vol. 06(2) pp. 4
drugs (fluoxetine) for, 1998, Vol. 12(3) pp. 4
drugs (galantamine) for, 2002, Vol. 16(4) pp. 5
drugs (mecamylamine) for, 1998, Vol. 12(4) pp. 2
drugs (olanzapine) for, 1999, Vol. 13(3) pp. 4
drugs (Pepcid) for, 2001, Vol. 15(2) pp. 6
drugs (Prozac) for, 1999, Vol. 13(2) pp. 2
drugs (risperidone) for, 1998, Vol. 12(3) pp. 1; 2001, Vol. 15(2) pp. 4; 2002, Vol. 16(4) pp. 6; 2003, Vol. 17(4) pp. 6.
Irwin, S. A., 2001, Vol. 15(2) pp. 4
Is This Your Child's World? (Rapp), 1998, Vol. 12(1) pp. 3
Isaacson, H. Ron, 1997, Vol. 11(3) pp. 1
Ishii, T., 1989, Vol. 03(2) pp. 1
Ishizaki, A., 1999, Vol. 13(4) pp. 6
Israngkun, Porn, 1987, Vol. 01(2) pp. 4
Ivarsson, S. A., 1990, Vol. 04(4) pp. 4
IVIG treatment. See intravenous gamma globulin
Iwata, Brian A., 1991, Vol. 05(1) pp. 5; 1991, Vol. 05(2) pp. 3; 1995, Vol. 09(2) pp. 5.
Iwata, Kazuo, 1989, Vol. 03(1) pp. 6
© copyright 2005, 2006 Autism Research Institute
|
|
